CTT Pharmaceutical Holdings’ CEO bought 10,100 shares at $0.04 each on 2026-09-22, taking the reported holding to 1,056,800 shares. The purchase represented about 1.0% of that resulting holding, giving investors a clear measure of the transaction against the reported post-purchase ownership position.

Key Highlights

  • CTT Pharmaceutical Holdings’ purchase was recorded at $0.04 per share.
  • The reported post-transaction position stood at 1,056,800 shares.
  • Transaction code P identifies the entry as an open-market purchase representing about 1.0% of the resulting holding.

CTT PHARMACEUTICAL HOLDINGS, INC. (OTC: CTTH), identified in the transaction as its CEO, bought 10,100 shares at $0.04 per share on 22 September 2026. CTTH is a Pharmaceuticals: Major company.

The reported ownership position after the transaction was 1,056,800 shares. The acquired stake accounted for about 1.0% of that resulting total. The transaction identifies CTT PHARMACEUTICAL HOLDINGS, INC. As the buyer and labels the role CEO. The purchase price applies at $0.04 for each share acquired.